<?xml version='1.0' encoding='ISO-8859-1'?>
<xml>
<title>Illinois General Assembly - Bill Status for HB 4624   </title>
<shortdesc>IDPH-DRUG REPOSITORY PROGRAM</shortdesc>
<sponsor>
<sponsorhead1>House Sponsors</sponsorhead1><sponsors>Rep. Kathleen A. Ryg-Jack D. Franks-Elizabeth Coulson</sponsors>
</sponsor>
<lastaction>
<statusdate>1/11/2005</statusdate><chamber>House</chamber><action>Session Sine Die</action>
</lastaction>
<synopsis>
<synopsistitle></synopsistitle>
<reference>New Act</reference><aliasreference></aliasreference><reference>225 ILCS 85/4</reference><aliasreference>from Ch. 111, par. 4124</aliasreference><reference>225 ILCS 120/15</reference><aliasreference>from Ch. 111, par. 8301-15</aliasreference><reference>320 ILCS 50/10</reference><aliasreference></aliasreference><reference>410 ILCS 620/16</reference><aliasreference>from Ch. 56 1/2, par. 516</aliasreference><reference>720 ILCS 570/102</reference><aliasreference>from Ch. 56 1/2, par. 1102</aliasreference><reference>740 ILCS 20/3</reference><aliasreference>from Ch. 70, par. 903</aliasreference><SynopsisText>     Creates the Drug Repository Program Act. Requires the Department of Public Health to establish a drug repository program to accept and dispense prescription drugs donated for the purpose of being dispensed to Illinois residents who meet eligibility standards adopted by the Department. Provides for donations of drugs by drug manufacturers and health care facilities. Prohibits the acceptance of drugs with an expiration date less than 6 months from the date the drug is donated. Provides immunity from civil and criminal liability for persons who donate, accept, or dispense drugs in accordance with the program. Amends the Pharmacy Practice Act of 1987, the Wholesale Drug Distribution Licensing Act, the Senior Pharmaceutical Assistance Act, the Illinois Food, Drug and Cosmetic Act, the Illinois Controlled Substances Act, and the Cannabis and Controlled Substances Tort Claims Act to provide that persons engaged in donating or accepting, or packaging, repackaging, or labeling, prescription drugs to the extent permitted or required under the Drug Repository Program Act are exempt from provisions of those other Acts that might prohibit or otherwise regulate such activity.</SynopsisText></synopsis>
<actions>
<statusdate>2/4/2004</statusdate><chamber>House</chamber><action>Filed with the Clerk by Rep. Kathleen A. Ryg</action>
<statusdate>2/4/2004</statusdate><chamber>House</chamber><action>Chief Co-Sponsor Rep. Jack D. Franks</action>
<statusdate>2/4/2004</statusdate><chamber>House</chamber><action>First Reading</action>
<statusdate>2/4/2004</statusdate><chamber>House</chamber><action>Referred to Rules Committee</action>
<statusdate>2/10/2004</statusdate><chamber>House</chamber><action>Added Chief Co-Sponsor Rep. Elizabeth Coulson</action>
<statusdate>1/11/2005</statusdate><chamber>House</chamber><action>Session Sine Die</action>
</actions>
</xml>

